+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amikacin"

From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Thumbnail Image

Aminoglycosides Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Amikacin is an aminoglycoside antibiotic used to treat a wide range of bacterial infections. It is effective against both gram-positive and gram-negative bacteria, and is often used in combination with other antibiotics. Amikacin is typically administered intravenously or intramuscularly, and is available in both generic and branded formulations. It is commonly used to treat infections of the urinary tract, respiratory tract, and skin and soft tissue. Amikacin is a widely used antibiotic, and is available in many countries around the world. It is often used in combination with other antibiotics, and is generally well tolerated with few side effects. It is also relatively inexpensive, making it an attractive option for treating bacterial infections. Some companies in the Amikacin market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. Show Less Read more